AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Ivabradine for Rate Control in Permanent Atrial Fibrillation

Phase 1

Completed

Conditions: Atrial Fibrillation, Persistent
Atrial Fibrillation

Interventions: Drug: Ivabradine

First Posted Date: 2019-06-14

Last Posted Date: 2021-07-02

Lead Sponsor: Yale University

Target Recruit Count: 4

Registration Number: NCT03987204

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Patient Reported Outcomes for Opioid Use Disorder

Completed

Conditions: Opioid-use Disorder
Overdose of Opiate
Patient Participation

First Posted Date: 2019-06-13

Last Posted Date: 2024-02-16

Lead Sponsor: Yale University

Target Recruit Count: 101

Registration Number: NCT03985163

Locations: 🇺🇸
Yale New Haven Hospital - York Street Campus - Emergency Department, New Haven, Connecticut, United States

The Role of Guideline-adherent Perioperative Antibiotic Administration and the Risk of Surgical Site Infections After Non-cardiac Surgery.

Withdrawn

Conditions: Surgical Site Infection
Antibiotic Prophylaxis

Interventions: Drug: Antibiotics

First Posted Date: 2019-06-12

Last Posted Date: 2022-07-25

Lead Sponsor: Yale University

Registration Number: NCT03982810

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Guanfacine to Improve Substance Use Outcomes in Women

Phase 2

Completed

Conditions: Substance Use Disorders

Interventions: Drug: Guanfacine
Other: Behavioral Counseling

First Posted Date: 2019-06-10

Last Posted Date: 2024-03-20

Lead Sponsor: Yale University

Target Recruit Count: 74

Registration Number: NCT03980184

Locations: 🇺🇸
The Yale Stress Center: Yale University, New Haven, Connecticut, United States

Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease

Phase 1

Terminated

Conditions: Sickle Cell Disease

Interventions: Drug: Dronabinol 2.5 MG
Drug: Microcrystalline cellulose

First Posted Date: 2019-06-06

Last Posted Date: 2021-01-26

Lead Sponsor: Yale University

Target Recruit Count: 6

Registration Number: NCT03978156

Locations: 🇺🇸
Yale New Haven Hospital Smilow Cancer Center, New Haven, Connecticut, United States

Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty

Phase 2

Completed

Conditions: Hip Arthropathy

Interventions: Procedure: Nerve Block
Procedure: Periarticular Injection (PAI)
Drug: Ropivacaine
Drug: Dex

First Posted Date: 2019-06-06

Last Posted Date: 2022-09-23

Lead Sponsor: Yale University

Target Recruit Count: 192

Registration Number: NCT03977454

Locations: 🇺🇸
Yale-New Haven Hospital St Raphael, New Haven, Connecticut, United States

The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA

Phase 1

Completed

Conditions: Healthy Participants

Interventions: Biological: Glucagon
Other: Control Study

First Posted Date: 2019-05-28

Last Posted Date: 2024-11-26

Lead Sponsor: Yale University

Target Recruit Count: 10

Registration Number: NCT03965130

Locations: 🇺🇸
Yale Hospital reserach Unit / YCCI, New Haven, Connecticut, United States

Evaluation and Management of Metabolic Bone Disease in Kidney Transplant Recipients

Not Applicable

Completed

Conditions: Kidney Transplant; Complications
Skeletal Anomalies

Interventions: Diagnostic Test: measurements to evaluate metabolic bone disease
Diagnostic Test: standard care

First Posted Date: 2019-05-22

Last Posted Date: 2023-02-28

Lead Sponsor: Yale University

Target Recruit Count: 8

Registration Number: NCT03958409

Locations: 🇺🇸
Yale Transplantation Center/Yale-New Haven Hospital, New Haven, Connecticut, United States

Approaches to Reduce Clinical Inertia in Hypertension in the Dominican Republic

Not Applicable

Withdrawn

Conditions: Hypertension

Interventions: Other: Multimodality behavioral strategy

First Posted Date: 2019-05-17

Last Posted Date: 2020-03-02

Lead Sponsor: Yale University

Registration Number: NCT03954951

Locations: 🇩🇴
Instituto Tecnologico de Santo Domingo, Santo Domingo, Dominican Republic

The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders

Early Phase 1

Completed

Conditions: Cocaine-Related Disorders

Interventions: Drug: Pregnenolone (PREG)
Drug: Placebos

First Posted Date: 2019-05-16

Last Posted Date: 2024-07-03

Lead Sponsor: Yale University

Target Recruit Count: 58

Registration Number: NCT03953612

Locations: 🇺🇸
Yale Stress Center, New Haven, Connecticut, United States

Home Terms & Conditions Privacy Policy